Global Biosimilars Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 06-Oct-2022
No. of pages: 104

The report focuses on the Biosimilars market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Biosimilars market.

Major Players in the Biosimilars market are:

Dr. Reddy's Laboratories

Pfizer Inc.

LG Life Sciences (LG Chem)

Novartis AG

Intas Pharmaceutical Ltd

Samsung Bioepis Co. Ltd

Coherus Biosciences Inc.

Eli Lilly and Company

Teva Pharmaceutical Industries Ltd

Biocad

Biocon Limited

Stada Arzneimittel AG

Amgen Inc.

Celltrion Healthcare

Mylan NV (Viatris Inc.)

On the basis of types, the Biosimilars market is primarily split into:

Monoclonal Antibodies

Recombinant Hormones

Immunomodulators

Anti-Inflammatory Agents

Others

On the basis of applications, the market covers:

Blood Disorders

Growth Hormonal Deficiency

Chronic and Autoimmune Disorders

Oncology

Others

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Biosimilars Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars Market
1.2 Biosimilars Market Segment by Type
1.2.1 Global Biosimilars Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Biosimilars Market Segment by Application
1.3.1 Biosimilars Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Biosimilars Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Biosimilars (2017-2029)
1.5.1 Global Biosimilars Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Biosimilars Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Biosimilars Industry
1.7 Impact of Carbon Neutrality on the Biosimilars Industry

2 Biosimilars Market Upstream and Downstream Analysis
2.1 Biosimilars Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Biosimilars Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Dr. Reddy's Laboratories
3.1.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Biosimilars Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Pfizer Inc.
3.2.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Biosimilars Market Performance (2017-2022)
3.2.4 Business Overview
3.3 LG Life Sciences (LG Chem)
3.3.1 LG Life Sciences (LG Chem) Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Biosimilars Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Novartis AG
3.4.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Biosimilars Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Intas Pharmaceutical Ltd
3.5.1 Intas Pharmaceutical Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Biosimilars Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Samsung Bioepis Co. Ltd
3.6.1 Samsung Bioepis Co. Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Biosimilars Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Coherus Biosciences Inc.
3.7.1 Coherus Biosciences Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Biosimilars Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Eli Lilly and Company
3.8.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Biosimilars Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Teva Pharmaceutical Industries Ltd
3.9.1 Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Biosimilars Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Biocad
3.10.1 Biocad Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Biosimilars Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Biocon Limited
3.11.1 Biocon Limited Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Biosimilars Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Stada Arzneimittel AG
3.12.1 Stada Arzneimittel AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Biosimilars Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Amgen Inc.
3.13.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Biosimilars Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Celltrion Healthcare
3.14.1 Celltrion Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Biosimilars Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Mylan NV (Viatris Inc.)
3.15.1 Mylan NV (Viatris Inc.) Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Biosimilars Market Performance (2017-2022)
3.15.4 Business Overview

4 Global Biosimilars Market Landscape by Player
4.1 Global Biosimilars Sales and Share by Player (2017-2022)
4.2 Global Biosimilars Revenue and Market Share by Player (2017-2022)
4.3 Global Biosimilars Average Price by Player (2017-2022)
4.4 Global Biosimilars Gross Margin by Player (2017-2022)
4.5 Biosimilars Market Competitive Situation and Trends
4.5.1 Biosimilars Market Concentration Rate
4.5.2 Biosimilars Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Biosimilars Sales, Revenue, Price Trend by Type
5.1 Global Biosimilars Sales and Market Share by Type (2017-2022)
5.2 Global Biosimilars Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilars Price by Type (2017-2022)
5.4 Global Biosimilars Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biosimilars Sales, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.2 Global Biosimilars Sales, Revenue and Growth Rate of Recombinant Hormones (2017-2022)
5.4.3 Global Biosimilars Sales, Revenue and Growth Rate of Immunomodulators (2017-2022)
5.4.4 Global Biosimilars Sales, Revenue and Growth Rate of Anti-Inflammatory Agents (2017-2022)
5.4.5 Global Biosimilars Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Biosimilars Market Analysis by Application
6.1 Global Biosimilars Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilars Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilars Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biosimilars Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.2 Global Biosimilars Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
6.3.3 Global Biosimilars Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
6.3.4 Global Biosimilars Consumption and Growth Rate of Oncology (2017-2022)
6.3.5 Global Biosimilars Consumption and Growth Rate of Others (2017-2022)

7 Global Biosimilars Sales and Revenue Region Wise (2017-2022)
7.1 Global Biosimilars Sales and Market Share, Region Wise (2017-2022)
7.2 Global Biosimilars Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Biosimilars Market Forecast (2022-2029)
8.1 Global Biosimilars Sales, Revenue Forecast (2022-2029)
8.1.1 Global Biosimilars Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Biosimilars Price and Trend Forecast (2022-2029)
8.2 Global Biosimilars Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.3 China Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.5 India Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Biosimilars Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Biosimilars Sales and Revenue Forecast (2022-2029)
8.3 Global Biosimilars Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Biosimilars Revenue and Growth Rate of Monoclonal Antibodies (2022-2029)
8.3.2 Global Biosimilars Revenue and Growth Rate of Recombinant Hormones (2022-2029)
8.3.3 Global Biosimilars Revenue and Growth Rate of Immunomodulators (2022-2029)
8.3.4 Global Biosimilars Revenue and Growth Rate of Anti-Inflammatory Agents (2022-2029)
8.3.5 Global Biosimilars Revenue and Growth Rate of Others (2022-2029)
8.4 Global Biosimilars Consumption Forecast by Application (2022-2029)
8.4.1 Global Biosimilars Consumption Value and Growth Rate of Blood Disorders (2022-2029)
8.4.2 Global Biosimilars Consumption Value and Growth Rate of Growth Hormonal Deficiency (2022-2029)
8.4.3 Global Biosimilars Consumption Value and Growth Rate of Chronic and Autoimmune Disorders (2022-2029)
8.4.4 Global Biosimilars Consumption Value and Growth Rate of Oncology (2022-2029)
8.4.5 Global Biosimilars Consumption Value and Growth Rate of Others (2022-2029)
8.5 Biosimilars Market Forecast Under COVID-19

9 Industry Outlook
9.1 Biosimilars Market Drivers Analysis
9.2 Biosimilars Market Restraints and Challenges
9.3 Biosimilars Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Biosimilars Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Biosimilars Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Biosimilars Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs